Armata Pharmaceuticals, Inc.
ARMP · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $14 | $15 | $10 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $3 | $2 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $10 | $2 |
| Total Curr. Assets | $11 | $19 | $27 | $15 |
| Property Plant & Equip (Net) | $55 | $57 | $47 | $38 |
| Goodwill | $3 | $3 | $3 | $3 |
| Intangibles | $10 | $10 | $10 | $10 |
| Long-Term Investments | $5 | $0 | $6 | $0 |
| Tax Assets | $0 | $0 | $12 | $0 |
| Other NC Assets | $1 | $8 | $2 | $3 |
| Total NC Assets | $75 | $79 | $81 | $55 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $86 | $98 | $108 | $70 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $6 | $1 |
| Short-Term Debt | $43 | $9 | $17 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $5 | $2 | $2 |
| Total Curr. Liab. | $48 | $16 | $25 | $5 |
| LT Debt | $83 | $111 | $32 | $36 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $3 | $3 | $15 | $3 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $86 | $114 | $47 | $40 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $32 | $38 | $32 | $38 |
| Total Liabilities | $134 | $130 | $72 | $44 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$328 | -$309 | -$240 | -$203 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $279 | $276 | $275 | $228 |
| Total Equity | -$48 | -$32 | $36 | $25 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $86 | $98 | $108 | $70 |
| Net Debt | $117 | $107 | $34 | $28 |